These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2594602)

  • 21. Treatment of hypercalcaemia with pamidronate in patients with end stage renal failure.
    Davenport A; Goel S; Mackenzie JC
    Scand J Urol Nephrol; 1993; 27(4):447-51. PubMed ID: 8159916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypercalcaemia in osteogenesis imperfecta treated with pamidronate.
    Williams CJ; Smith RA; Ball RJ; Wilkinson H
    Arch Dis Child; 1997 Feb; 76(2):169-70. PubMed ID: 9068314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D intoxication causes hypercalcaemia by increased bone resorption which responds to pamidronate.
    Selby PL; Davies M; Marks JS; Mawer EB
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):531-6. PubMed ID: 8548936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe prolonged hypocalcaemia following pamidronate for malignant hypercalcaemia.
    Sims EC; Rogers PB; Besser GM; Plowman PN
    Clin Oncol (R Coll Radiol); 1998; 10(6):407-9. PubMed ID: 9890546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pamidronate and calcitonin as therapy of acute cancer-related hypercalcemia in children.
    Schmid I; Stachel D; Schön C; Bauer M; Haas RJ
    Klin Padiatr; 2001; 213(1):30-4. PubMed ID: 11225473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe immobilization-induced hypercalcemia in a child after liver transplantation successfully treated with pamidronate.
    Profumo RJ; Reese JC; Foy TM; Garibaldi LR; Kane RE
    Transplantation; 1994 Jan; 57(2):301-3. PubMed ID: 8310527
    [No Abstract]   [Full Text] [Related]  

  • 27. Leukaemia-associated hypercalcaemia in a 10-year-old boy: effectiveness of aminohydroxypropylidene biphosphonate.
    Boudailliez BR; Pautard BJ; Sebert JL; Kremp O; Piussan CX
    Pediatr Nephrol; 1990 Sep; 4(5):510-1. PubMed ID: 2242318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fast (4-h) or slow (24-h) infusions of pamidronate disodium (aminohydroxypropylidene diphosphonate (APD)) as single shot treatment of hypercalcaemia.
    Sawyer N; Newstead C; Drummond A; Cunningham J
    Bone Miner; 1990 May; 9(2):121-8. PubMed ID: 2350615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose of bisphosphonate for hypercalcaemia of malignancy.
    Morton AR; Friefeld J; Halperin F
    Lancet; 1990 Jun; 335(8703):1469-70. PubMed ID: 1972245
    [No Abstract]   [Full Text] [Related]  

  • 30. [Combination therapy with pamidronate and calcitonin in hypercalcemic crisis caused by primary hyperparathyroidism].
    Christensen JH; Kristiansen JH
    Ugeskr Laeger; 1992 Nov; 154(47):3341-2. PubMed ID: 1462441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pamidronate (Aredia, Ciba) in malignant hypercalcaemia.
    MacConnachie AM
    Intensive Crit Care Nurs; 1997 Feb; 13(1):58-9. PubMed ID: 9095884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
    Sekine M; Takami H
    Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diphosphonates in the treatment of hypercalcemia].
    Delmas PD; Meunier PJ
    Rev Med Interne; 1984 Nov; 5(4):363-6. PubMed ID: 6240753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immobilization hypercalcemia treatment with pamidronate disodium after spinal cord injury.
    Massagli TL; Cardenas DD
    Arch Phys Med Rehabil; 1999 Sep; 80(9):998-1000. PubMed ID: 10488998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia.
    Ralston SH; Gardner MD; Dryburgh FJ; Jenkins AS; Cowan RA; Boyle IT
    Lancet; 1985 Oct; 2(8461):907-10. PubMed ID: 2865417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immobilization hypercalcaemia due to low bone formation and responding to intravenous sodium sulphate.
    Evans RA; Lawrence PJ; Thanakrishnan G; Hills E; Wong SY; Dunstan CR
    Postgrad Med J; 1986 May; 62(727):395-8. PubMed ID: 3763550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical experience with aminohydroxypropylidene bisphosphonate (APD) in the management of cancer-associated hypercalcaemia.
    Ralston SH; Alzaid AA; Gallacher SJ; Gardner MD; Cowan RA; Boyle IT
    Q J Med; 1988 Oct; 68(258):825-34. PubMed ID: 3268894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic disturbances after a single dose of 30 mg pamidronate for leukaemia-associated hypercalcaemia in a 11-year-old boy.
    De Schepper J; de Pont S; Smitz J; De Coster D; Schots R; Otten J
    Eur J Pediatr; 1999 Sep; 158(9):765-6. PubMed ID: 10485313
    [No Abstract]   [Full Text] [Related]  

  • 39. Severe infantile hypercalcemia associated with Williams syndrome successfully treated with intravenously administered pamidronate.
    Cagle AP; Waguespack SG; Buckingham BA; Shankar RR; Dimeglio LA
    Pediatrics; 2004 Oct; 114(4):1091-5. PubMed ID: 15466114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immobilization-related hypercalcemia after renal failure in burn injury.
    Peralta MC; Gordon DL
    Endocr Pract; 2002; 8(3):213-6. PubMed ID: 12113635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.